D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
PUT
Ambarella
AMBA
$2.91B
| $1.3M | ﹤0.01% |
30,000
-40,000
| -57% | -$1.58M |
|
|
SYKE
2402
DELISTED
SYKES Enterprises Inc
SYKE
| $1.3M | ﹤0.01% |
45,825
-7,518
| -14% | -$212K |
|
|
AKCA
2403
DELISTED
Akcea Therapeutics Inc
AKCA
| $1.29M | ﹤0.01% |
+45,676
| New | +$1.33M |
|
2404
CALL
Strategic Education
STRA
$1.83B
| $1.29M | ﹤0.01% |
9,800
+3,530
| +56% | +$430K |
|
2405
CALL
DXC Technology
DXC
$1.77B
| $1.29M | ﹤0.01% |
20,000
-55,000
| -73% | -$3.52M |
|
|
2406
PUT
DXC Technology
DXC
$1.77B
| $1.29M | ﹤0.01% |
20,000
| – | – |
|
2407
Grupo Aval
AVAL
$5.53B
| $1.28M | ﹤0.01% |
164,949
-66,919
| -29% | -$481K |
|
2408
SLR Investment Corp
SLRC
$709M
| $1.28M | ﹤0.01% |
61,645
+49,898
| +425% | +$1.04M |
|
2409
Helix Energy Solutions
HLX
$1.39B
| $1.28M | ﹤0.01% |
162,336
+16,800
| +12% | +$120K |
|
|
SMI
2410
DELISTED
Semiconductor Manufacturing Intl
SMI
| $1.28M | ﹤0.01% |
253,751
+83,187
| +49% | +$401K |
|
2411
Crane NXT
CXT
$3.14B
| $1.28M | ﹤0.01% |
43,585
-13,612
| -24% | -$385K |
|
2412
Zions Bancorporation
ZION
$10.1B
| $1.28M | ﹤0.01% |
+28,193
| New | +$1.35M |
|
|
LTXB
2413
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $1.28M | ﹤0.01% |
34,236
+22,912
| +202% | +$895K |
|
2414
Liberty Latin America Class A
LILA
$1.63B
| $1.27M | ﹤0.01% |
+102,889
| New | +$1.2M |
|
|
AQ
2415
DELISTED
Aquantia Corp. Common Stock
AQ
| $1.27M | ﹤0.01% |
+140,347
| New | +$1.2M |
|
2416
CALL
Avis
CAR
$5.88B
| $1.27M | ﹤0.01% |
36,400
+18,200
| +100% | +$545K |
|
|
ADAP
2417
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.27M | ﹤0.01% |
294,573
+80,412
| +38% | +$374K |
|
|
NBL
2418
PUT
DELISTED
Noble Energy, Inc.
NBL
| $1.27M | ﹤0.01% |
51,200
+30,000
| +142% | +$679K |
|
2419
The GEO Group
GEO
$4.11B
| $1.26M | ﹤0.01% |
65,900
-520,498
| -89% | -$11.2M |
|
2420
VEON
VEON
$3.55B
| $1.26M | ﹤0.01% |
+24,187
| New | +$1.51M |
|
2421
CALL
Ollie's Bargain Outlet
OLLI
$4.18B
| $1.26M | ﹤0.01% |
14,800
| – | – |
|
2422
Allegion
ALLE
$14B
| $1.26M | ﹤0.01% |
13,900
-9
| -0.1% | -$783 |
|
2423
Aqua Metals
AQMS
$9.63M
| $1.26M | ﹤0.01% |
+2,054
| New | +$1.14M |
|
|
JOYY
2424
CALL
JOYY Inc
JOYY
$3.85B
| $1.26M | ﹤0.01% |
15,000
-69,300
| -82% | -$5.04M |
|
2425
Talos Energy
TALO
$2.37B
| $1.26M | ﹤0.01% |
47,400
-25,340
| -35% | -$550K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.